Dr. Lal Path Labs Ltd.
LALPATHLAB · Hospitals · NSE
₹1,408
Current Market Price
Fair Value (DCF)
₹788
Margin of Safety
-44.0%
Updated just now
YieldIQ Score
31/100
Piotroski F-Score
8/9
Economic Moat
Moderate
Confidence
32%
ROE
22.1%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.24 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
28.0%
Return on capital employed
EV / EBITDA
29.6×
Enterprise multiple
Debt / EBITDA
0.2×
Leverage vs earnings
Interest Coverage
29.0×
EBIT covers interest
Current Ratio
3.39×
Short-term liquidity
Asset Turnover
0.91×
Revenue per ₹ of assets
Revenue CAGR (3Y)
5.6%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,407.9
Bear case
₹450.02
MoS -212.9%
Base case
₹788.1
MoS -78.6%
Bull case
₹1,111.08
MoS -26.7%
Ratio Trends
LALPATHLAB · last 9 annual periods
ROE
22.1%
ROCE
33.4%
Operating Margin
—
Debt / Equity
0.07×
PE
268.2×
EV / EBITDA
28.5×
Historical Financials
LALPATHLAB · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1581 Cr | ₹2087 Cr | ₹491 Cr | ₹479 Cr | ₹2461 Cr | +11.7% |
| EBITDA | — | ₹613 Cr | ₹532 Cr | ₹678 Cr | ₹789 Cr | +6.5% |
| EBIT | ₹410 Cr | ₹505 Cr | ₹92.2 Cr | ₹126 Cr | — | -25.5% |
| PAT | ₹297 Cr | ₹350 Cr | ₹56.9 Cr | ₹89.5 Cr | ₹487 Cr | +13.2% |
| EPS (diluted) | ₹35.25 | ₹41.57 | ₹6.82 | ₹10.71 | — | -25.8% |
| CFO | ₹398 Cr | ₹447 Cr | ₹456 Cr | ₹478 Cr | ₹569 Cr | +9.3% |
| CapEx | — | — | — | — | ₹-53.9 Cr | — |
| FCF | — | — | — | — | ₹515 Cr | +0.0% |
| Total Assets | — | ₹2353 Cr | ₹2386 Cr | ₹2415 Cr | ₹2717 Cr | +3.7% |
| Total Debt | — | — | ₹153 Cr | ₹83.3 Cr | ₹157 Cr | +0.7% |
| Shareholders' Equity | — | — | ₹1666 Cr | ₹1900 Cr | ₹2206 Cr | +7.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
LALPATHLAB vs 1 closest peer by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SAILIFE SAILIFE | — | — | Pending | 8.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
25 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹50.00/sh
Last payout
2026-02-05
₹3.50
Peak payout
₹6.00
Trailing yield
0.92%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of LALPATHLAB →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for LALPATHLAB →
Compare
Head-to-head with peers
Compare LALPATHLAB side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse LALPATHLABNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.